Use Able AI chat for product recommendations

ZCCHC3 Polyclonal antibody

ZCCHC3 Polyclonal Antibody for WB, ELISA

Cat No. 29399-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

Human and More (1)

Applications

WB, IHC, ELISA

C20orf99, ZCCHC3

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inHEK-293 cells, HepG2 cells, K-562 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:8000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

29399-1-AP targets ZCCHC3 in WB, IHC, ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag30047

Product name: Recombinant human ZCCHC3 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-171 aa of NM_033089

Sequence: MATGGGAEEERKRGRPQLLPPARPAARGEEADGGREKMGWAQVVKNLAEKKGEFREPRPPRREEESGGGGGSAGLGGPAGLAAPDLGDFPPAGRGDPKGRRRDPAGEAVDPRKKKGAAEAGRRKKAEAAAAAMATPARPGEAEDAAERPLQDEPAAAAGPGKGRFLVRICF

Predict reactive species
Full Name zinc finger, CCHC domain containing 3
Calculated Molecular Weight 44 kDa
Observed Molecular Weight 43-45 kDa
GenBank Accession NumberNM_033089
Gene Symbol ZCCHC3
Gene ID (NCBI) 85364
RRIDAB_2918294
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9NUD5
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for ZCCHC3 antibody 29399-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanIHC

Pathol Int

Combined use of immunoreactivities of Efp and ZCCHC3 for predicting prognosis of patients with triple-negative breast cancer

Authors - Akihiro Fujimoto
humanWB

Biochem Biophys Res Commun

ZCCHC3 and Efp coordinately contribute to the pathophysiology of triple-negative breast cancer by modulating NCAPH

Authors - Akihiro Fujimoto
  • KD Validated

Cell Genom

Repeats mimic pathogen-associated patterns across a vast evolutionary landscape

Authors - Petr Šulc
humanIHC

Pathol Int

Immunoreactivities of ZCCHC3 and Efp in the High-Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors.

Authors - Erina Iwabuchi
Loading...
||
New chat

Able

正在加载,请稍候...